MarketPulse

CFO stock sale

3 articles
The Motley FoolThe Motley Fool··Cory Renauer

Dianthus CFO Sells $739K in Stock as Biotech Eyes Phase 3 Success

Dianthus Therapeutics CFO Ryan Savitz sold 8,224 shares for $739,000 on April 9, 2026, reducing direct holdings to zero while retaining substantial options.
DNTHmonoclonal antibodybiotech
The Motley FoolThe Motley Fool··Robert Izquierdo

C3.ai Stock Faces Headwinds Despite CFO Share Sale; Analysts Urge Caution

C3.ai's CFO sold 15,248 shares for tax purposes, a non-concerning move. However, the stock remains unattractive amid 59.9% decline, CEO departure, and sharp revenue drop.
AIvaluationrevenue decline
The Motley FoolThe Motley Fool··Adé Hennis

RealReal CFO Dumps $336K in Stock as Luxury Resale Platform Faces 2026 Headwinds

RealReal CFO sells $336K in stock amid 22% 2026 decline, despite Q4 earnings beat and strong year-over-year gains.
REALearnings beatinsider selling